Literature DB >> 29681214

Pathogenesis of epileptic seizures and epilepsy after stroke.

Huajun Yang1,2,3,4, Gary Rajah5, Anchen Guo2,3,4, Yongjun Wang1,2,3,4, Qun Wang1,2,3,4.   

Abstract

Stroke is an important cause of seizures and epilepsy in adults, particularly among the elderly. The incidence of stroke increases yearly as life expectancy increases and the number of patients with post-stroke seizures and epilepsy is also rising. Post-stroke epilepsy accounts for nearly 50% of newly diagnosed epilepsy among patients over 60 years of age. With increasing stroke awareness and advanced treatments, increased attention is paid to post-stroke seizures and epilepsy including its diagnosis and treatment. There has been a plethora of research on the pathogenesis of seizures and epilepsy after stroke. And thus, the research advances in the pathogenesis and related therapeutic targets of post-stroke seizures and epilepsy will be reviewed in this article.

Entities:  

Keywords:  Stroke; epilepsy; pathogenesis; seizure

Mesh:

Year:  2018        PMID: 29681214     DOI: 10.1080/01616412.2018.1455014

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  11 in total

Review 1.  Can Old Animals Reveal New Targets? The Aging and Degenerating Brain as a New Precision Medicine Opportunity for Epilepsy.

Authors:  Aaron Del Pozo; Leanne Lehmann; Kevin M Knox; Melissa Barker-Haliski
Journal:  Front Neurol       Date:  2022-04-28       Impact factor: 4.086

2.  The 100 most-cited articles about the role of neurovascular unit in stroke 2001-2020: A bibliometric analysis.

Authors:  Lv Xie; Bingwei Lu; Yezhi Ma; Jiemin Yin; Xiaozhu Zhai; Chen Chen; Wanqing Xie; Yueman Zhang; Li Zheng; Peiying Li
Journal:  CNS Neurosci Ther       Date:  2021-03-25       Impact factor: 5.243

3.  New-Onset Geriatric Epilepsy in China: A Single-Center Study.

Authors:  Jian-Hua Chen; Xiang-Qin Zhou; Qiang Lu; Li-Ri Jin; Yan Huang
Journal:  Chin Med J (Engl)       Date:  2018-12-20       Impact factor: 2.628

4.  Risk Factors for Epilepsy After Thrombolysis for Ischemic Stroke: A Cohort Study.

Authors:  Rosane Brondani; Andrea Garcia de Almeida; Pedro Abrahim Cherubini; Thaís Leite Secchi; Marina Amaral de Oliveira; Sheila Cristina Ouriques Martins; Marino Muxfeldt Bianchin
Journal:  Front Neurol       Date:  2020-01-23       Impact factor: 4.003

5.  Cognitive dysfunction in Nigerian women with epilepsy on carbamazepine and levetiracetam monotherapy.

Authors:  Luqman Ogunjimi; Joseph Yaria; Akintomiwa Makanjuola; Akinyinka Alabi; Bamidele Osalusi; David Oboh; Mojisola Olusola-Bello; Adeyinka Aderinola; Adesola Ogunniyi
Journal:  Brain Behav       Date:  2021-03-05       Impact factor: 2.708

6.  Risk of ischaemic stroke associated with antiepileptic drugs: a population-based case-control study in Catalonia.

Authors:  Maria Giner-Soriano; Josep Ramon Marsal; Ainhoa Gomez-Lumbreras; Rosa Morros
Journal:  BMC Neurol       Date:  2021-05-24       Impact factor: 2.474

7.  Asymmetric distribution of enlarged perivascular spaces in centrum semiovale may be associated with epilepsy after acute ischemic stroke.

Authors:  Nian Yu; Benjamin Sinclair; Lina Maria Garcia Posada; Zhibin Chen; Qing Di; Xingjian Lin; Scott Kolbe; Gernot Hlauschek; Patrick Kwan; Meng Law
Journal:  CNS Neurosci Ther       Date:  2022-01-03       Impact factor: 5.243

Review 8.  Neurovascular unit dysfunction as a mechanism of seizures and epilepsy during aging.

Authors:  Erwin A van Vliet; Nicola Marchi
Journal:  Epilepsia       Date:  2022-04-21       Impact factor: 6.740

9.  Association between IL-1β and recurrence after the first epileptic seizure in ischemic stroke patients.

Authors:  Qingyan Zhang; Guanghong Li; Duanyun Zhao; Peng Yang; Tuerxun Shabier; Tuerhong Tuerxun
Journal:  Sci Rep       Date:  2020-08-11       Impact factor: 4.379

10.  Positive Effect of α-Asaronol on the Incidence of Post-Stroke Epilepsy for Rat with Cerebral Ischemia-Reperfusion Injury.

Authors:  Lan Jiang; Xiangnan Hu
Journal:  Molecules       Date:  2022-03-18       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.